t.varga
TL2 Moderator · Kolkata
Contributes reviews on supplier material. Based in Kolkata.
Joined 12 July 2025 · last posted 2d
83Posts here
3Topics
1Solutions
166Likes received
184Likes given
20Badges
93Days visited
1.1kPosts read
Recent activity
Full stream-
Second pass at: When your prescriber and the evidence disagree Replied, post #56 · Clinical › Prescriber conversations · 26 Jul 2026 · 10 likes I read post #54 twice before replying, because I had assumed the opposite. Preparing for an appointment: bring recent bloodwork, a list of current medications with…
-
GLP-1 receptor distribution: central and peripheral Replied, post #95 · Pharmacology › Receptor biology · 21 Jul 2026 · 31 likes Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor distinct from GLP-1. The hypothesis behind combination therapy is two…
-
An 18-month record including the parts that went badly Replied, post #73 · Outcomes › Progress reports · 18 Jul 2026 · 27 likes Picking up post #70: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #50 · Practice › Side effects · 14 Jul 2026 · 14 likes On post #46 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #3 · marked as the solution · Compounds › Retatrutide · 13 Jul 2026 · 9 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
What is genuinely unknown about long-term amylin agonism Replied, post #24 · Compounds › Cagrilintide & amylin analogues · 11 Jul 2026 · 0 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
-
Follow-up: Reading an interaction checker output critically Replied, post #38 · Practice › Interactions · 9 Jul 2026 · 0 likes I read post #36 twice before replying, because I had assumed the opposite. Metformin: commonly co-administered and relevant to gastrointestinal tolerability.…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Started this topic · Practice › Interactions · 5 Jul 2026 · 2 likes Delayed gastric emptying and oral medication absorption: which drugs matter Writing it up because I had to work it out twice and would rather nobody else did. I have…
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #37 · Documentation › Doc review · 2 Jul 2026 · 30 likes Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the evidence here. The maintainer will review and correct if you…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #34 · Research Methods › Statistics · 1 Jul 2026 · 12 likes post #33 is right about the mechanism and I think understates the practical bit. Power and sample size: a study might be too small to detect a real effect (low power).…
-
NHS criteria and how they are applied in practice Replied, post #14 · Regional › UK & Ireland · 29 Jun 2026 · 11 likes Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate.…
-
Aggregate verification data across the directory, with caveats Replied, post #18 · Sourcing › Independent verification · 28 Jun 2026 · 7 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…